Evidence map›Paper›PMID 36498621›Full record

ArticleJournal of clinical medicine2022

An Approach to Identify HLA Class II Immunogenic Epitopes in the Greek Population through Machine Learning Algorithms.

Asimina Fylaktou, Georgios Lioulios, Katerina Tarassi, Alexandra Siorenta, George Ch Petasis, Demetris Gerogiannis, Ioannis Theodorou, Aliki G Iniotaki, Angeliki G Vittoraki

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Asimina FylaktouNational Peripheral Histocompatibility Center, Immunology Department, Hippokration General Hospital, 54642 Thessaloniki, Greece.
Georgios LiouliosNational Peripheral Histocompatibility Center, Immunology Department, Hippokration General Hospital, 54642 Thessaloniki, Greece.
Katerina TarassiImmunology-Histocompatibility Department, "Evangelismos" General Hospital, 10676 Athens, Greece.
Alexandra SiorentaImmunology Department & National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", 11527 Athens, Greece.
George Ch PetasisNational Peripheral Histocompatibility Center, Immunology Department, Hippokration General Hospital, 54642 Thessaloniki, Greece.ORCID 0000-0001-8150-6334
Demetris GerogiannisDepartment of Computer Science & Engineering, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0003-0798-6709
Ioannis TheodorouLaboratoire d'Immunologie, Hôpital Robert Debre, 75010 Paris, France.ORCID 0000-0002-8337-1661
Aliki G IniotakiImmunology Department & National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", 11527 Athens, Greece.
Angeliki G VittorakiImmunology Department & National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", 11527 Athens, Greece.
General Hospital of Athens G. Genimatas · GRHippocration General Hospital · GREvangelismos Hospital · GRHôpital Robert-Debré · FRUniversity of Ioannina · GR

Funding

Hellenic Society of Immunology 9/29.01.2019
6 · The paper itself

Abstract

Current pre-transplantation routine matching involves serum anti-HLA antibodies quantification but cannot always preclude unfavorable graft outcomes. Epitope-based matching is proposed as a more precise approach, but to date no epitope-matching algorithm provides a satisfactory predictive tool for transplantation outcomes. In this study, anti-HLA-II loci responses from 1748 patients were analyzed with unsupervised machine learning algorithms, namely principal component analysis (PCA) and antigenic distances, projected as dendrograms. PCA for anti-HLA-DR anti-bodies revealed three main clusters of responses: anti-HLA-DR51 combined with anti-HLA-DRB1*01, anti-HLA-DR52 combined with anti-HLA-DRB1*08 and anti-HLA-DR53 combined with anti-HLA-DRB1*10. The dendrogram for anti-HLA-DR confirmed the pattern and showed further bisection of each cluster. Common epitopes present exclusively in all HLA molecules of each cluster were determined following the HLA epitope registry. Thus, we propose that 19 out of 123 HLA-DR epitopes are those that mainly lead anti-HLA-DR responses in the studied population. Likewise, we identified 22 out of 83 epitopes responsible for anti-HLA-DQ and 13 out of 62 responsible for anti-HLA-DP responses. Interpretation of these results may elucidate mechanisms of interlocus cross-reactivity, providing an alternative way of estimating the significance of each epitope in a population and thus suggesting a novel strategy towards optimal donor selection.

Indexed as

alloimmune responseanti-HLA class II responsesepitope matchingepletsmachine learningtransplantation

Identifiers

PMID36498621
PMCPMC9738260
OpenAlexW4310363560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.